Business Context and Reporting Period
This Form 8-K Current Report is filed by Bristol-Myers Squibb Company (BMY) for the reporting period ending March 1, 2021. The filing primarily addresses corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statement data.
Material Changes
- Board Composition: Mr. Dinesh Paliwal notified the company on March 1, 2021, that he will not stand for re-election to the Board of Directors at the 2021 Annual Meeting of Shareholders.
- Director Count: The Board has set the number of directors at ten, effective as of the 2021 Annual Meeting of Shareholders.
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, risk factors, or contingencies. The 2021 Annual Meeting of Shareholders is expected to be held on May 4, 2021.
Key Facts for Investor Verification
- Mr. Dinesh Paliwal will not seek re-election to the Board.
- The Board size is being reduced to ten directors effective at the upcoming annual meeting.
- The 2021 Annual Meeting is scheduled for May 4, 2021.
- No financial performance data is included in this specific filing.